Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Geun-Woo Jin"'
Autor:
Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki-yeok Kim, Geun-woo Jin, Jin-Ho Choy
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 486 (2021)
COVID-19 has been affecting millions of individuals worldwide and, thus far, there is no accurate therapeutic strategy. This critical situation necessitates novel formulations for already existing, FDA approved, but poorly absorbable drug candidates,
Externí odkaz:
https://doaj.org/article/930614d05a7548b49abdcee8bcffa826
Publikováno v:
Biomolecules, Vol 8, Iss 3, p 48 (2018)
Retinoic acid (RA) is a bioactive lipid that has been shown to promote neural stem cell differentiation. However, the highly hydrophobic molecule needs to first solubilize and translocate across the cell membrane in order to exert a biological respon
Externí odkaz:
https://doaj.org/article/6ccf8fdfaca249ddbef06eea52e42291
Autor:
Geun-Woo Jin, Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Shunsuke Asahina, Soo-Jin Choi, Hwa Jeong Lee, Jin-Ho Choy
Publikováno v:
Journal of materials chemistry. B.
To date, cancer therapies largely consist of five pillars: surgery, radiation, chemotherapy, targeted therapy, and immunotherapy. Still, researchers are trying to innovate the current cancer therapies to pursue an ideal one without side effects. For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8da879ee458a0f0ce09932ce599c9b
https://pubmed.ncbi.nlm.nih.gov/36354057
https://pubmed.ncbi.nlm.nih.gov/36354057
Autor:
Geun-woo Jin, Goeun Choi, N. Sanoj Rejinold, Huiyan Piao, Young Bae Ryu, Hyung-Jun Kwon, In Chul Lee, Jin-Ho Choy
The COVID-19 pandemic is a serious global health threat mainly due to the surging cases along with new variants of COVID-19. Though global vaccinations have indeed some effects on the virus spread, its longevity is still unknown. Therefore an orally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ec13b705a98498ed9f981a47fcd0f27
https://doi.org/10.1101/2022.07.19.500639
https://doi.org/10.1101/2022.07.19.500639
Publikováno v:
Clays and Clay Minerals
The ongoing pandemic, COVID-19 (SARS-CoV-2), has afflicted millions of people around the world, necessitating that the scientific community work, diligently and promptly, on suitable medicaments. Although vaccination programs have been run globally,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8db11f90dea7464352eaa62c0892a6
https://pubmed.ncbi.nlm.nih.gov/34785820
https://pubmed.ncbi.nlm.nih.gov/34785820
Publikováno v:
Colloids and Surfaces. B, Biointerfaces
Graphical abstract
COVID-19 is a rapidly evolving emergency, which necessitates scientific community to come up with novel formulations that could find quick relief to the millions affected around the globe. Remdesivir being the only injectable
COVID-19 is a rapidly evolving emergency, which necessitates scientific community to come up with novel formulations that could find quick relief to the millions affected around the globe. Remdesivir being the only injectable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140d2b632cb50ce795b4a5e2df680d19
https://pubmed.ncbi.nlm.nih.gov/34482191
https://pubmed.ncbi.nlm.nih.gov/34482191
Autor:
Geun-woo Jin, N. Sanoj Rejinold, Ki-yeok Kim, Goeun Choi, Seungjin Yu, Jin-Ho Choy, Huiyan Piao
Publikováno v:
Pharmaceuticals
Volume 14
Issue 5
Pharmaceuticals, Vol 14, Iss 486, p 486 (2021)
Volume 14
Issue 5
Pharmaceuticals, Vol 14, Iss 486, p 486 (2021)
COVID-19 has been affecting millions of individuals worldwide and, thus far, there is no accurate therapeutic strategy. This critical situation necessitates novel formulations for already existing, FDA approved, but poorly absorbable drug candidates,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d9a057bc48eda6e94b9d5df69b959b
http://europepmc.org/articles/PMC8160721
http://europepmc.org/articles/PMC8160721
Publikováno v:
Microporous and Mesoporous Materials
COVID-19 is a rapidly evolving emergency, for which there have been no specific medication found yet. Therefore, it is necessary to find a solution for this ongoing pandemic with the aid of advanced pharmaceutics. What is proposed as a solution is th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0816221c43d26c17209a07bb550437
https://pubmed.ncbi.nlm.nih.gov/34483712
https://pubmed.ncbi.nlm.nih.gov/34483712
Publikováno v:
Polymers
Volume 13
Issue 7
Polymers, Vol 13, Iss 1044, p 1044 (2021)
Volume 13
Issue 7
Polymers, Vol 13, Iss 1044, p 1044 (2021)
Niclosamide (NIC), a conventional anthelmintic agent, is emerging as a repurposed drug for COVID-19 treatment. However, the clinical efficacy is very limited due to its low oral bioavailability resulting from its poor aqueous solubility. In the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a4ce338ffa22859f40deebeaec8e30
https://pubmed.ncbi.nlm.nih.gov/33810527
https://pubmed.ncbi.nlm.nih.gov/33810527
Publikováno v:
MicroRNA Technologies ISBN: 9781493971732
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49b1ee676f2736ebcebc3e3982292f39
https://doi.org/10.1007/7657_2016_11
https://doi.org/10.1007/7657_2016_11